Personalising Deformable Image Registration with Clinical Context and Deformation History for Adaptive Radiotherapy

Adaptive radiotherapy must account for anatomical changes during treatment, but doing so depends on reliably mapping targets, organs at risk and dose across serial images.

By Jiang, Zhao, Ding +23Oct 13, 2026

Score████░░░░░░3.6

Key numbers

84.76% to 96.92% relative to
45.0% to 82.5% for clinical
22.5% to 62.5% for organs

Caveats

Not randomized: its findings are associations.
Preprint; not yet peer reviewed.

VerdictWorth a reader's time today.

Read the original PDF

Abstract

Adaptive radiotherapy must account for anatomical changes during treatment, but doing so depends on reliably mapping targets, organs at risk and dose across serial images. Existing registration methods treat each image pair independently, without using radiotherapy-specific context or the patient's preceding anatomical trajectory. We developed Clinical-context-Aware and Patient-adaptive Deformable Image Registration (CAP-DIR), integrating source contours, dose, clinical text and prior-registration features. We evaluated 16,361 CT examinations from 3,473 patients across four institutional cohorts and five public benchmarks. CAP-DIR increased internal-test organ-at-risk-region normalized cross-correlation from 84.76% to 96.92% relative to the strongest learning-based comparator, with low deformation folding, and remained superior across seven external cohorts. In a blinded review of 20 longitudinal cases, clinically acceptable contours increased from 45.0% to 82.5% for clinical target volumes and from 22.5% to 62.5% for organs at risk, while estimated editing time decreased. In a controlled benchmark, CAP-DIR reduced global dose-mapping error by 34.5% relative to the strongest comparator. These findings show that clinically informed, longitudinal registration can improve contour usability and dose mapping for adaptive radiotherapy.

Caiwen Jiang, Songlin Zhao, Yuzhen Ding, Jia Mi, Samir H. Patel, Alexandra Bennett, Keldon K. Lin, Terence T. Sio, Jonathan B. Ashman, Lisa A. McGee, Jean-Claude M. Rwigema, William G. Rule, Sameer R. Keole, Sujay A. Vora, William W. Wong, Nathan Y. Yu, Michele Y. Halyard, Steven E. Schild, Safia K. Ahmed, Daniel J. Ma, Robert L. Foote, Michelle A. Neben Wittich, Thomas J. Whitaker, Haibo Lin, Dinggang Shen, Wei Liu

The editor's rubric

Heuristic review

Dimension	Level	Weight	What that level means
Leverage	███░░ 3	24%	A method or resource many groups across the field will adopt within a year.
Magnitude	███░░ 3	18%	Large gain: roughly 2x, or a clear new state of the art on a hard, unsaturated problem.
Evidence	███░░ 3	14%	Solid: multiple benchmarks or cohorts, ablations, fair baselines, released code or data.
Novelty	██░░░ 2	16%	A new combination of known ideas.
Trajectory	██░░░ 2	18%	Some room to improve with obvious engineering.
Stakes	███░░ 3	10%	Meaningful benefit to many people within a few years.

Editor’s rationale

Heuristic triage from title and abstract text only, not a reading of the paper. Cues found: breadth (many tasks); gains (relative gain, outperforms); design (blinded); verification (multiple benchmarks, independent replication); stakes (global scale, prevention or cure). Red flags: not randomized.

How the score was computed

rank-2026-10-07

Score████░░░░░░3.6

Score = 10 × (65% × adjusted merit / 10 + 25% × attention + 10% × freshness)

Merit: 5.3 / 10; Weighted rubric, evidence-gated.
Adjusted merit: 4.6 / 10; Shrunk toward the desk prior by editor confidence (46%).
Attention: 0%; Citations, upvotes, points, mentions.
Freshness: 60%; Half-life decay since publication.

No attention signals recorded yet.

The record

Reviewed by heuristic-v6 on Oct 15, 2026, 02:05 UTC. Paper type: clinical.
Categories: eess.IV, cs.AI
BRIEF, No.6 in the Medicine edition of October 15, 2026.